.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 3,972,934

« Back to Dashboard

Details for Patent: 3,972,934

Title: 3-Substituted phenylalkyl amines
Abstract:Novel 3-phenoxyphenylalkyl amines and the amides, alcohols, tetrazoles, and carbamates related thereto as well as novel intermediates useful in the preparation of such compounds. The compounds of this invention are useful as anti-inflammatory, analgesic, and antipyretic agents.
Inventor(s): Marshall; Winston S. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Filing Date:Mar 10, 1971
Application Number:05/122,999
Claims:1. A compound of the formula ##SPC3##

wherein R.sub.1 is hydrogen, C.sub.1 to C.sub.5 -alkyl, C.sub.2 to C.sub.5 -alkenyl, C.sub.2 -C.sub.5 -alkynyl; n is an integer of from 1 to 3; and each R.sub.5 is the same or different and is hydrogen, C.sub.1 to C.sub.5 -alkyl, C.sub.2 to C.sub.6 -alkenyl, cyclopropyl, or cyclopropylmethyl, allyl, 3-methyl-2-butenyl, or phenethyl; and the pharmaceutically acceptable acid addition salts thereof.

2. A compound as defined in claim 1 wherein R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 1, and ##STR45## each R.sub.5 is hydrogen, and the pharmaceutically acceptable acid addition salts thereof.

3. A compound as defined in claim 2 wherein the compound is 2-(3-phenoxyphenyl)propylamine hydrochloride.

4. A compound as defined in claim 1 wherein R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 1 and ##STR46## one R.sub.5 is hydrogen and the other R.sub.5 is C.sub.1 to C.sub.5 -alkyl, and the pharmaceutically acceptable acid addition salts thereof.

5. A compound as defined in claim 4 wherein the compound is 2-(3-phenoxyphenyl)-N-methylpropyl amine hydrochloride.

6. A compound as defined in claim 1 wherein R.sub.1 is hydrogen, n is 1, and ##STR47## each R.sub.5 is hydrogen, and the pharmaceutically acceptable acid addition salts thereof.

7. A compound as defined in claim 6 wherein the compound is 2-(3-phenoxyphenyl)ethylamine hydrochloride.

8. A compound as defined in claim 1 wherein R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 1, and ##STR48## one R.sub.5 is C.sub.1 to C.sub.5 -alkyl and the other R.sub.5 is C.sub.3 to C.sub.6 -cycloalkyl, and the pharmaceutically acceptable acid addition salts thereof.

9. A compound as defined in claim 8 wherein the compound is 2-(3-phenoxyphenyl)-N-methyl-N-cyclopropyl-propylamine hydrochloride.

10. A compound as defined in claim 1 where R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 2, and ##STR49## each R.sub.5 is hydrogen, and the pharmaceutically acceptable acid addition salts thereof.

11. A compound as defined in claim 10 wherein the compound is 3-(3-phenoxyphenyl)butylamine hydrochloride.

12. A compound as defined in claim 1 wherein R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 1, and ##STR50## one R.sub.5 is C.sub.1 to C.sub.5 -alkyl and the other R.sub.5 is C.sub.2 to C.sub.6 -alkenyl, and the pharmaceutically acceptable salts thereof.

13. A compound as defined in claim 12 wherein the compound is 2-(3-phenoxyphenyl)-N-allyl-N-methyl-propylamine hydrochloride.

14. A compound as defined in claim 12 wherein the compound is 2-(3-phenoxyphenyl)-N-methyl-N-(3-methyl-2-butenyl)propylamine hydrochloride.

15. A compound as defined in claim 1 wherein R.sub.1 is C.sub.1 to C.sub.5 -alkyl, n is 1, and ##STR51## one R.sub.5 is hydrogen and the other R.sub.5 is C.sub.3 to C.sub.6 -cycloalkyl, and pharmaceutically acceptable salts thereof.

16. A compound as defined in claim 15 wherein the compound is 2-(3-phenoxyphenyl)-N-cyclopropyl-propylamine hydrochloride.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc